Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US 8,999,372 In forceTerm ends Apr 29, 2027 · From the USPTO record
20-year base term ended Mar 28, 2023
Mar 28, 2003
Apr 29, 2027
Apr 7, 2015
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 28, 2003, when the earliest non-provisional application in its chain was filed (this one was filed Mar 7, 2006); a parent in its chain could not be resolved (the next row) | Mar 28, 2023 | From the USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | From the USPTO record |
| Patent term adjustment | +1493 days, USPTO patent term adjustment record | Apr 29, 2027 | From the USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | From the USPTO record |
| Patent term extension | None on file | no change | From the USPTO record |
| Fee events | 2 of 3 maintenance fees paid | In force | From the USPTO record |
| Computed term end | The steps above, in order | Apr 29, 2027 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.